Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: New Constructs, LLC
Provider: Wright Reports
Provider: MacroRisk Analytics/EconomicInvestor

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Arrhythmia Research Technology Inc Announces Management Change-Form 8-K

Friday, 29 Mar 2013 05:23pm EDT 

Arrhythmia Research Technology Inc reported in its Form 8-K that on March 25, 2013, Mr. Michael S. Gunter resigned as a Director of Arrhythmia Research Technology, Inc. (Company) and Micron Products, Inc. (Micron Products) effective immediately and notified the Board that his service as Interim Chief Executive Officer (CEO) of the Company would end on March 31, 2013, namely, the end of the period during which he agreed to serve in such position. On March 28, 2013, the Board of Directors appointed Salvatore Emma, Jr., as President and Chief Executive Officer (CEO) of the Company, Micron Products, and of the Company's other subsidiaries effective April 1, 2013. 

Company Quote

-0.01 -0.16%
23 Oct 2014